VIRSIK PETER (Chief Operating Officer) sold 5.5% of their position (694.00 shares) of ESSA PHARMA INC. on the open market
Open‑market sale worth $5.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/5/2024ACC: 0000950172-24-000180
Officer· Chief Operating Officer
Since Oct 2020
-694.00
Net shares
Net seller
$5.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
694.00 disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−694.00
Price / share
$7.94
Trade value
$5.51K
% of position
5.5%
4/5/2024
12.63K→11.94K
Total
Net shares
−694.00
Net value
-$5.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 4/5/2024 | S · Sale | −694.00 | $7.94 | $5.51K | 5.5% | 12.63K | 11.94K |
| Total | −694.00 | -$5.51K | ||||||
Derivative Transactions0
No derivative transactions reported